<DOC>
	<DOCNO>NCT02604004</DOCNO>
	<brief_summary>The objective research check whether test drug ( lamivudine form coat tablet 150 mg ) achieve plasma level equivalent obtain EPIVIR form coat tablet 150 mg GlaxoSmithKline administer 28 volunteer genre fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Between Lamivudine Formulations Form Coated Tablet 150 mg Healthy Volunteers</brief_title>
	<detailed_description>It open , randomize , crossover 2x2 , single dose , administration medicine 28 healthy volunteer , adult age 18-50 year , gender ( 14 male 14 female ) . Of 28 volunteer plan study protocol start , give one ( woman ) start Phase I . So study initiate complete participation 27 volunteer . The volunteer hospital period approximately 36 hour stage .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Considered healthy undergoing clinical evaluation ; Agree freely sign Recruitment Informed Consent Term , content protocol clear procedure ; Present body mass index great 19 less 30 . Results laboratory test outside range consider normal , unless consider clinically irrelevant ; Allergic lamivudine drug ; Positive outcome preadmission pregnancy test ; Regular medication within four ( 4 ) week prior start study use medication present interaction lamivudine one week start study ; Use abusive alcoholic beverage ; Use illicit drug tobacco ; History liver disease , renal , pulmonary , gastrointestinal , epileptic , hematologic psychiatric ; hypo hypertension cause required pharmacological treatment ; myocardial infarction , angina / heart failure ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>lamivudine</keyword>
	<keyword>bioequivalence test</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>high-performance liquid chromatography</keyword>
	<keyword>3TC</keyword>
	<keyword>LC-MS/MS</keyword>
	<keyword>mass spectrometry</keyword>
</DOC>